Progress Reported in Search for MERS Treatment

After the death toll from the MERS virus topped 100 in Saudi Arabia, US scientists say they have made progress toward developing treatments for it.

There are currently no vaccines or antiviral treatments for MERS, a severe respiratory disease with a mortality rate of more than 40 percent that was first reported in Saudi Arabia in 2012 and which experts are still struggling to understand.

Middle East Respiratory Syndrome (MERS) - Causes Symptoms Treatment Prevention
MERS, a newly discovered respiratory disease, was recently reported in the Arabian region. MERS is caused by a virus similar to that causing common cold and other respiratory illnesses.

But now scientists at the Dana-Farber Cancer Institute in Boston have identified natural human antibodies -- proteins made by the immune system that recognize foreign viruses and bacteria -- against the virus that causes MERS.

In laboratory studies reported in the Proceedings of the National Academy of Sciences (PNAS), a scientific journal, researchers found that these "neutralizing" antibodies prevented a key part of the virus, known as MERS CoV, from attaching to protein receptors that allow the virus to infect human cells.

Further experiments are under way that could lead to development of antibody preventives and treatments for MERS, according to the scientists.

Alarm Bells Ringing in Mideast Due to Deadly MERS Virus Outbreak
Amid criticism faced that Saudi Arabia was not doing enough to contain the deadly MERS virus, the country has just reportedly confirmed an outbreak of the disease.

"This panel of neutralizing antibodies offers the possibility of developing human monoclonal antibody-based immunotherapy, especially for health care workers," the authors noted.

MERS is considered a deadlier but less-transmissible cousin of the SARS virus that erupted in Asia in 2003 and infected 8,273 people, nine percent of whom died.

Gene Mapping may Give Valuable Insight on the Spread of MERS Virus
Gene profiling of the MERS virus may provide valuable insights about how the microbe spreads, researchers from Britain and Saudi Arabia claim

The UN agency said the recent cluster of cases among health workers was a cause of concern as the virus had clearly been contracted from a human patient and not directly from an animal host.

Wayne Marasco, who led the research, and his team found the MERS antibodies using a "library" of some 27 billion human antibodies they have created and maintain in a freezer at Dana-Farber.

Camels From Saudi Arabia Carry MERS Virus!
Around 75% of the camels recently surveyed in Saudi Arabia have been found to be infected with the MERS coronavirus which is responsible for human cases of MERS

A neutralizing antibody is one that not only recognizes a specific virus but also prevents it from infecting host cells, so eventually the infection is "cleared" from the individual.

Marasco added that an antibody-based treatment for MERS would be administered by injection and could provide protection for about three weeks.

Source-AFP